Become an Intellectual Property Lawyer.

Lawyers in India practice across three broad streams: (1) corporate / transactional law — M&A, capital markets, banking and finance, private equity, IP, employment, dispute resolution at tier-1 firms like Cyril Amarchand Mangaldas (CAM), AZB & Partners, Shardul Amarchand Mangaldas (SAM), Trilegal, Khaitan & Co, Luthra & Luthra, J Sagar Associates (JSA), Nishith Desai Associates, Argus, IndusLaw, Talwar Thakore; (2) litigation — Supreme Court / High Court chambers practice including senior-advocate-led teams (Harish Salve, Mukul Rohatgi, Fali Nariman before him, Kapil Sibal, Abhishek Manu Singhvi, Gopal Subramanium, Salman Khurshid, Indira Jaising), High Court trial chambers, district court / sessions court practice; (3) in-house counsel — at Indian corporates (Reliance, Tata Sons, Aditya Birla Group, Infosys, TCS, HDFC Bank, Bharti Airtel) and foreign multinationals (Google India, Microsoft India, Amazon India, Goldman Sachs India). The Indian path runs through 5-year integrated B.A.LL.B / B.B.A.LL.B at National Law Universities (NLSIU Bangalore, NALSAR Hyderabad, WBNUJS Kolkata, NLU Delhi, GNLU Gujarat, NLU Jodhpur — collectively the 'NLU' brand), or 3-year LL.B after graduation at Delhi University Faculty of Law, Government Law Colleges (Mumbai, Pune), Jindal Global Law School (private premium), Symbiosis Law School, Christ University Bengaluru, ILS Pune; followed by Bar Council of India enrolment via the All India Bar Examination (AIBE). Pay varies extremely: tier-1 firm fresh NLU graduate starts at ₹17-22L/year all-in (CAM, AZB, SAM, Trilegal, Khaitan); senior associate at 5-7 years ₹40-80L; salaried partner ₹1-3Cr; equity partner ₹2-10Cr+. Senior advocates at the Supreme Court charge ₹10-25L per appearance for the top tier and ₹50L-2Cr+ for marquee constitutional / corporate disputes. Litigation chambers practice early on pays ₹0-3L for the first 3-5 years before income builds.

Civil lawyers in India represent clients in non-criminal disputes before district civil courts, High Courts, consumer fora, RERA authorities, family courts, and the National Company Law Tribunal — covering property, contract, succession, matrimonial, and recovery matters governed by the Code of Civil Procedure 1908 (CPC). The bulk of civil court volume flows through property title disputes, loan-recovery suits, RERA complaints against builders, divorce and maintenance under the Hindu Marriage Act 1955 and Special Marriage Act 1954, succession and probate applications under the Indian Succession Act, and money-recovery suits under Order XXXVII (summary suits). Established independent advocates in tier-1 cities with a strong property or matrimonial client base earn ₹25-80L annually; district court specialists in tier-2 cities stabilise at ₹8-20L after 5-7 years. Entry into civil practice is via LL.B / B.A.LL.B enrolment with a State Bar Council followed by junior work under a senior advocate, and the AIBE from the Bar Council of India.

Criminal lawyers in India represent accused persons, complainants, and the state in offences under the Bharatiya Nyaya Sanhita (BNS) 2023 (replacing IPC), the Bharatiya Nagarik Suraksha Sanhita (BNSS) 2023 (replacing CrPC), POCSO Act, Narcotic Drugs and Psychotropic Substances (NDPS) Act, Prevention of Money Laundering Act (PMLA), Unlawful Activities (Prevention) Act (UAPA), and the Bharatiya Sakshya Adhiniyam (BSA) 2023 (replacing the Evidence Act). Practice runs from district sessions courts — where bail applications, chargesheet challenges, and trials are conducted — up to High Courts for anticipatory bail, revision petitions, quashing petitions under Section 528 BNSS, and to the Supreme Court on special leave petitions and constitutional challenges. Leading practitioners include Senior Advocates Kapil Sibal, Mukul Rohatgi, Siddharth Luthra, Sidharth Aggarwal, Rebecca John, Vrinda Grover, and N. Hariharan, whose PMLA and UAPA practices define the ceiling of what the criminal bar commands. Entry income is low but growth tracks courtroom standing, not credentials alone — a skilled advocate who builds a Sessions Court reputation can earn ₹15-30L by year 5-7 without ever attending a tier-1 law firm.

Corporate lawyers in India practice exclusively in the transactional stream — structuring and executing M&A deals, private equity investments, capital markets transactions (IPOs, QIPs, NCDs under SEBI ICDR), banking and finance documentation (facility agreements, debenture trust deeds, ECB), and day-to-day corporate governance under the Companies Act 2013. Unlike litigators who appear in court, corporate lawyers produce paper: SHA, SPA, DRHP, board resolutions, FEMA compounding applications, and CCI merger-control filings. The primary employers are India's tier-1 law firms — AZB & Partners, Cyril Amarchand Mangaldas (CAM), Shardul Amarchand Mangaldas (SAM), Khaitan & Co, JSA, Trilegal, L&L Partners, Nishith Desai Associates, IndusLaw — plus in-house legal teams at Reliance Industries, Tata Sons, TCS, Infosys, HDFC Bank, and Bharti Airtel, and the Big-4 legal arms (KPMG Legal, EY Law, Deloitte Legal). Entry is almost entirely through National Law Universities (NLUs) via CLAT; a US or UK LLM is the accepted credential for international capital markets work.

Tax lawyers in India litigate and advise on direct and indirect tax disputes before the Income Tax Appellate Tribunal (ITAT), Customs Excise and Service Tax Appellate Tribunal (CESTAT), Authority for Advance Rulings (AAR / Board for Advance Rulings), and the High Courts and Supreme Court — fields where Harish Salve, Arvind Datar, Sohrab Dastur, S. Ganesh, and Tarun Gulati command ₹5–50 Cr per matter and set the standard for advocacy. Unlike Chartered Accountants who file returns and give advisory opinions, or tax auditors who sign Form 3CD, the tax lawyer's core function is courtroom argumentation — drafting grounds of appeal, framing jurisdictional objections, writing writ petitions challenging CBDT circulars, and appearing before tax authorities from the Assessing Officer to the Supreme Court bench. Practice runs across income tax (Sections 9, 40A, 56, 68, 115BB, 153A, 263), GST and legacy indirect taxes (CESTAT appeals, DRC-07/08 SCN responses), transfer pricing litigation (TPO orders to ITAT Special Bench), and international treaty disputes (equalization levy, royalty vs FTS under Section 195, Vodafone-type capital gains re-characterization). Firms defining the field include Lakshmikumaran & Sridharan, Vaish Associates, Nishith Desai Associates, Khaitan & Co tax litigation team, Economic Laws Practice (ELP), and Shardul Amarchand Mangaldas.

International Tax Consultants advise Indian and multinational corporates on the tax consequences of cross-border transactions — applying Double Taxation Avoidance Agreements (DTAAs), General Anti-Avoidance Rules (GAAR), OECD BEPS Action Plans (including Pillar 1 equalization and Pillar 2 global minimum tax), and India's withholding tax framework to structures involving multiple jurisdictions. Unlike domestic tax consultants who focus on Income Tax Act returns, GSTR compliance, and ITAT litigation, international tax specialists live in Article-level treaty analysis — determining whether a payment under Article 7 (business profits), Article 12 (royalties), or Article 13 (capital gains) of the India-US, India-Mauritius, India-Singapore, or India-Netherlands DTAA is taxable in India. In India, this is primarily a Big-4 practice (Deloitte, EY, KPMG, PwC) and tier-1 boutique practice (Nishith Desai Associates, Cyril Amarchand Mangaldas, AZB & Partners, Vaish Associates), with growing in-house international tax teams at Infosys, TCS, Wipro, and the large banking and pharma conglomerates whose cross-border flows generate continuous treaty exposure.

Senior: N/A

An Indian Economic Service (IES) Officer is a Group A central-government economist, recruited through the UPSC IES Examination, who provides professional economic analysis to Union ministries and constitutional bodies. Officers are posted to the Department of Economic Affairs (DEA), NITI Aayog, Ministry of Commerce, Ministry of Agriculture, Ministry of Finance's EA Wing, and on deputation to the RBI. Core work spans drafting the Economic Survey of India (the flagship pre-Budget document authored from within the Economic Adviser's office), preparing fiscal-multiplier estimates for the Union Budget, advising on monetary-fiscal coordination with the RBI, staffing Parliamentary Committees on finance and economic legislation, and producing macro-research briefs for Cabinet-level decisions. Entry is at the Assistant Director level (Pay Level 10, ₹56,100 basic), with a career ladder reaching Principal Economic Adviser or Secretary (EA) at the apex and occasionally the Chief Economic Adviser to the Government of India. The IES cadre numbers ~500 officers, making it significantly smaller and more specialist than the IAS, and virtually every officer works on live policy questions — there is no equivalent of a district-administration posting.

Senior: ₹30.0L

Infertility Specialists (Reproductive Endocrinologists and Infertility, REI) are OBG super-specialists who evaluate and treat the full spectrum of causes preventing conception — from unexplained infertility and male-factor semen defects to diminished ovarian reserve, uterine anomalies, tubal-factor disease, and recurrent implantation failure. In India the specialty sits at the intersection of rapidly advancing ART technology and a booming private IVF market estimated at ₹5,000 crore annually (growing 15-20% YoY): chains like Nova IVI Fertility (50+ centres), Indira IVF (100+ centres), Bloom IVF, Cloudnine ART, Apollo Fertility, and Cradle Fertility have made IVF accessible in tier-2 cities. The training path is MBBS + MS Obstetrics & Gynaecology (3 years via NEET-PG) followed by a 2-3 year Fellowship in Reproductive Medicine (DNB-accredited or FOGSI/ISAR-recognised), with premier positions at AIIMS, PGIMER, NIMHANS, KEM Mumbai, CMC Vellore, and all major IVF chains. Practice is governed by the ART (Regulation) Act 2021 and Surrogacy (Regulation) Act 2021 — compliance-heavy, ethically complex, and institutionally structured.

Senior: N/A

Endocrinologists are internal-medicine super-specialists who diagnose and manage disorders of the endocrine system — the network of glands that produce and regulate hormones controlling metabolism, growth, reproduction, and stress response. In India, the specialty is defined by the country's status as the diabetes capital of the world (101 million diabetics, 136 million pre-diabetics as of 2023 IDF data): a typical endocrinology OPD in a tier-1 city sees 40-80 patients daily, the majority for Type 2 diabetes optimisation, HbA1c audit, insulin initiation, GLP-1 receptor agonist (liraglutide, semaglutide) and SGLT2i (dapagliflozin, empagliflozin) titration against ADA and RSSDI guidelines. Beyond diabetes, the practice covers thyroid nodules and thyroid cancer follow-up, primary hyperparathyroidism, Addison's disease, Cushing's syndrome and disease, pituitary adenomas (prolactinoma, acromegaly, Cushing's disease), polycystic ovarian syndrome (PCOS), male hypogonadism, growth hormone deficiency in children and adults, and osteoporosis with fracture-risk stratification. The training path is MBBS + MD General Medicine (or MD Paediatrics for paediatric endocrinology) + DM Endocrinology — one of the most competitive DM seats in India, with AIIMS and PGIMER taking fewer than 5-8 candidates per year. Premier practice destinations are MV Hospital for Diabetes Chennai (Dr V. Mohan's institution, the largest diabetes centre in Asia), Madras Medical Mission, AIIMS Delhi, PGIMER Chandigarh, Apollo Hospitals, Fortis, Medanta, and the rapidly growing private endocrinology-plus-diabetology clinic model in metro India.

Senior: N/A

Rheumatologists are internists who have completed DM Rheumatology (or equivalent Fellowship) and manage the full spectrum of autoimmune and musculoskeletal disease — rheumatoid arthritis (RA), ankylosing spondylitis (AS), systemic lupus erythematosus (SLE), vasculitis, psoriatic arthritis, myositis, and crystal arthropathies like gout. The Indian training path is MBBS + MD General Medicine (3 years via NEET-PG) + DM Rheumatology (3 years via NEET-SS) — making it one of the longest specialisation tracks in Indian medicine (11.5 years total). India has roughly 800-1,000 practicing rheumatologists for 1.4 billion people, creating an extreme access gap that translates directly into high clinical demand and significant practice income for trained specialists. Premier training centres are AIIMS Delhi (which opened India's first dedicated DM Rheumatology programme), PGIMER Chandigarh, CMC Vellore, SGPGI Lucknow, IPGMER Kolkata, Amrita Kochi, and KEM Mumbai. Private practice anchors are Apollo, Fortis, Manipal, and Kokilaben Dhirubhai Ambani Hospital, where urban rheumatology OPDs run 60-100 patients a day across multiple consultants. The biologics market — anti-TNF agents (adalimumab, etanercept), IL-6 inhibitors (tocilizumab), JAK inhibitors (tofacitinib, baricitinib), anti-CD20 (rituximab), IL-17 inhibitors (secukinumab) — is growing at 15-20% annually in India and has materially increased both the complexity and the income ceiling of modern rheumatology practice.

Senior: N/A